G Wells

Minimal clinically important differences: review of methods.

B Shea, P Tugwell, P. Tugwell, 2001, The Journal of rheumatology.

When is a randomised controlled trial health equity relevant? Development and validation of a conceptual framework

C Weijer, M Taljaard, B Shea, 2017, BMJ Open.

Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.

P Tugwell, B Combe, G. Koch, 2008, Arthritis and rheumatism.

Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration.

J J Anderson, G. Wells, D. Felson, 2000, Arthritis and rheumatism.